Powders: Clinical Trials

65 trials of Powders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 completed, 12 unknown, 5 terminated, 3 not yet recruiting. 21 Phase 1, 16 Not applicable, 11 Phase 2, 8 Phase 3, 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 121Completed 17, Not yet recruiting 2, Recruiting 1, Withdrawn 1
Not applicable16Completed 10, Unknown 4, Active not recruiting 1, Terminated 1
Phase 211Completed 4, Unknown 3, Not yet recruiting 2, Terminated 2
Phase 38Completed 2, Terminated 2, Unknown 2, Active not recruiting 1, Recruiting 1
Phase 48Completed 4, Unknown 3, Terminated 1
Early Phase 11Recruiting 1

Follow Powders: new trials by email Literature Review of Powders trials Research Report on Powders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Dose-Response of Bletilla Formosana in Prediabetic Subjects
Bletilla formosana (BF) powder, Placebo - Prediabetes
Phase 1 / Phase 2Not yet recruitingChang Gung Memorial Hospital942026-07-012026-07-15
Role of Medication in Making Urine Less Acidic as Part of Kidney Stone Prevention
Potassium Citrate Extended Release Oral Tablet - Kidney Calculi
Phase 1Not yet recruitingUniversity of Texas Southwestern Medical Center202026-07-012026-02-05
Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy
Biospecimen Collection, Placebo Administration, Probiotic - Advanced Ovarian Carcinoma, Recurrent Ovarian Carcinoma
Early Phase 1RecruitingOhio State University Comprehensive Cancer Center1612026-03-062026-08-17
Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum
5% 5-fluorouracil (5-FU) powder, 5% 5-fluorouracil (5-FU) powder PLUS 15% Aluminum Chloride Hexahydrate (ACH) - Actinic Keratoses
Phase 1RecruitingWest Virginia University322026-02-062026-04-22
Remimazolam vs. Midazolam for Sedation and Cognitive Outcomes in Orthopedic Surgery
Midazolam, REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO] - Postoperative Cognitive Dysfunction, Orthopedic Procedures
Phase 3RecruitingRomanian Society for Enteral and Parenteral Nutrition1202025-10-012025-10-01
Intravenous Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)
alpha1-proteinase inhibitor, produced from the plasma of human donors (Prolastin 1000 mg, powder and solvent for solution for infusion), Placebo - Acute Exacerbation Chronic Obstructive Pulmonary Disease
Phase 2Not yet recruitingFondazione IRCCS Policlinico San Matteo di Pavia362025-10-012025-08-24
Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions
RLF-OD032 100 mg/mL oral suspension, Kuvan 100 MG Powder for Oral Solution - Bioequivalence
Phase 1CompletedAPR Applied Pharma Research s.a.422025-08-202026-04-28
A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions
Cannabidiol (CBD) Powder, Cannabidiol 100 MG/ML [Epidiolex] - CBD Pharmacokinetics, Healthy Participants
Phase 1Completeddsm-firmenich Switzerland AG322024-08-302024-12-17
Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients with Pneumonia.
TAD® 600 mg/4 mL powder and solvent for solution for injection, Saline solution 0.9% of sodium chloride - Pneumonia, Myocardial Injury
Phase 3UnknownBiomedica Foscama S.p.A. Industria Chimico-Farmaceutica1782024-06-252024-11-27
A Bioequivalence Study of Two Different Dosage Form of Genakumab
Genakumab Injection (T, Solution for injection), Genakumab for Injection (R, Powder for solution for injection) - Gouty Arthritis (GA)
Phase 1CompletedChangchun GeneScience Pharmaceutical Co., Ltd.1782024-06-242025-02-11
Effects of Prebiotics on Metagenomic Diversity and Abundance in Young Children With Acute Malnutrition
Prebiotic galacto-oligosaccharide (GOS) Powder, Starch Only, RUTF + Starch - Child Malnutrition
Not applicableUnknownUniversity of the Punjab2002024-01-012023-12-04
Evaluation of Premixed Verses Powder/Liquid Bioceramic MTA in Indirect Pulp Capping.
Premixed MTA, Powder/liquid MTA - Indirect Pulp Capping
Not applicableUnknownCairo University242023-01-012022-12-05
95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment
Dexmedetomidine, Remimazolam tosilate - Lung Cancer, Anesthesia Induction
Not applicableCompletedShiyou Wei1152022-12-012023-03-14
Understanding Dose Related Effects of Strawberry
freeze-dried whole strawberry powder 36 g powder, freeze-dried whole strawberry powder 12 g, freeze-dried control powder 0 g strawberry - Pre-diabetes, Insulin Sensitivity
Not applicableCompletedClinical Nutrition Research Center, Illinois Institute of Technology682022-08-312026-08-28
Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol
REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO], Flumazenil, Propofol - Recovery
Not applicableCompletedSeoul National University Hospital662022-08-022023-01-13
Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients
REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO], Propofol, Rocuronium - Hemodynamic Instability
Not applicableCompletedSeoul National University Hospital1062022-07-262023-11-22
Caffeine Dose: Performance and Recovery
Cellulose Powder, Caffeine 3 mg/kg Oral Powder, Caffeine 6 mg/kg Oral Powder - Healthy Volunteers, Caffeine
Not applicableCompletedUlaç Can YILDIRIM132022-07-242025-07-29
Intralesional Injection of Acyclovir Versus Candida Antigen in Treatment of Plantar Warts
Acyclovir 250mg Powder for Solution for Infusion, each vial contains 250mg of acyclovir as the sodium salt, Chandra Bhagat Pharma Pvt. Ltd andcandida antigen - Acyclovir and Candida Antigen in Treatment of Plantar Wart
Phase 4UnknownSohag University402022-06-132022-06-23
Effects of "For-Baby" Supplementation on Young Children's Physical Growth and Diarrhea Episodes
"For Baby "supplements provided as powder, Micronutrient powder provided as powder - Children, Malnutrition
Not applicableUnknownLao Tropical and Public Health Institute12002022-03-202022-03-04
Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients
L-Glutamine, Oral Powder for Reconstitution, Standard of care - Sickle Cell Disease
Phase 4CompletedAin Shams University602022-01-042024-01-09

Showing 20 of 65. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (4)  ·  Lung Neoplasms (3)  ·  Bacterial Infections (2)  ·  Leukemia (2)  ·  Malnutrition (2)  ·  Pneumonia (2)  ·  Pneumonia, Ventilator-Associated (2)  ·  Urogenital Neoplasms (2)  ·  Anemia, Sickle Cell (1)  ·  Arthritis, Gouty (1)  ·  Asthma (1)  ·  Bronchitis (1)  ·  Cachexia (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)

Sponsors

NanOlogy, LLC (5)  ·  Daiichi Sankyo (2)  ·  GlaxoSmithKline (2)  ·  Medicines for Malaria Venture (2)  ·  Seoul National University Hospital (2)  ·  APR Applied Pharma Research s.a. (1)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Ain Shams University (1)  ·  Apeptico Forschung und Entwicklung GmbH (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azidus Brasil (1)  ·  Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica (1)  ·  Boston Children's Hospital (1)  ·  Bristol-Myers Squibb (1)  ·  Cairo University (1)

Countries

United States (16)  ·  France (4)  ·  Italy (4)  ·  Canada (3)  ·  Germany (3)  ·  Austria (2)  ·  Brazil (2)  ·  China (2)  ·  Egypt (2)  ·  Netherlands (2)  ·  South Korea (2)  ·  Switzerland (2)  ·  Taiwan (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)

Top investigators

Shelagh Verco, PhD (2)  ·  Yunseok Jeon, MD, PhD (2)  ·  Ahlem Trifi (1)  ·  Alyssa Lebel, MD (1)  ·  Ana Maria Dumitriu, MD, PhD (1)  ·  Anthony Bier, MD (1)  ·  Arnon Blum, MD (1)  ·  Aya H Ali (1)  ·  Barry Reece, MBA (1)  ·  Britt Burton-Freeman, PhD (1)  ·  Cornelius Koch, MD (1)  ·  David Keefe, MD (1)  ·  Elisabeth Kruse, PhD (1)

Results publications

PMID 10465169, PMID 10933492, PMID 11148177, PMID 11874817, PMID 12045122, PMID 12740257, PMID 12826636, PMID 15050036, PMID 15683545, PMID 18565211, PMID 19197072, PMID 19553648, PMID 19845686, PMID 20843247, PMID 21060150, PMID 21367592, PMID 21486454, PMID 21680942, PMID 22123804, PMID 22447964, PMID 22634722, PMID 23526215, PMID 23975926, PMID 23989916, PMID 25299856, PMID 25628520, PMID 25754526, PMID 26026936, PMID 26282478, PMID 26304913, PMID 26523330, PMID 26732025, PMID 27033711, PMID 27191923, PMID 27564664, PMID 27916480, PMID 28404617, PMID 28846134, PMID 29719508, PMID 29859851, PMID 30081867, PMID 30237305, PMID 30965011, PMID 31179005, PMID 32060059, PMID 32356465, PMID 3261353, PMID 33069326, PMID 33288475, PMID 33483869

NIH funding

2009 (1), 2015 (1), 2018 (1)